Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Publication
, Journal Article
Streiff, MB; Holmstrom, B; Angelini, D; Ashrani, A; Buckner, T; Diep, R; Fertrin, KY; Fogerty, AE; Crestani, NG; Gangaraju, R; Goldhaber, SZ ...
Published in: J Natl Compr Canc Netw
September 2024
The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease provide strategies for the prevention, diagnosis, and treatment of venous thromboembolism (VTE) in adult patients with cancer. VTE is a common and life-threatening condition in patients with cancer, and its management often requires multidisciplinary efforts. The NCCN panel is comprised of specialists spanning various fields, including cardiology, hematology, medical oncology, internal medicine, interventional radiology, and pharmacology. The content featured in this issue specifically addresses the evaluation and recommended treatment options outlined in the NCCN Guidelines for the diverse subtypes of cancer-associated VTE.
Duke Scholars
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
September 2024
Volume
22
Issue
7
Start / End Page
483 / 506
Location
United States
Related Subject Headings
- Venous Thromboembolism
- Oncology & Carcinogenesis
- Neoplasms
- Medical Oncology
- Humans
- Disease Management
- Anticoagulants
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Streiff, M. B., Holmstrom, B., Angelini, D., Ashrani, A., Buckner, T., Diep, R., … Sliker, B. (2024). Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 22(7), 483–506. https://doi.org/10.6004/jnccn.2024.0046
Streiff, Michael B., Bjorn Holmstrom, Dana Angelini, Aneel Ashrani, Tyler Buckner, Robert Diep, Kleber Yotsumoto Fertrin, et al. “Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 22, no. 7 (September 2024): 483–506. https://doi.org/10.6004/jnccn.2024.0046.
Streiff MB, Holmstrom B, Angelini D, Ashrani A, Buckner T, Diep R, et al. Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 Sep;22(7):483–506.
Streiff, Michael B., et al. “Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw, vol. 22, no. 7, Sept. 2024, pp. 483–506. Pubmed, doi:10.6004/jnccn.2024.0046.
Streiff MB, Holmstrom B, Angelini D, Ashrani A, Buckner T, Diep R, Fertrin KY, Fogerty AE, Crestani NG, Gangaraju R, Rojas-Hernandez C, Goldhaber SZ, Ibrahim I, Kubal T, Leavitt AD, Lim M, Mann J, Mantha S, Morton C, Nester A, O’Brien A, Ortel TL, Pine A, Pishko A, Ranade M, Salmasi A, Schaefer J, Williams E, Wool G, Wun T, Montgomery S, Nguyen J, Freedman-Cass D, Sliker B. Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 Sep;22(7):483–506.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
September 2024
Volume
22
Issue
7
Start / End Page
483 / 506
Location
United States
Related Subject Headings
- Venous Thromboembolism
- Oncology & Carcinogenesis
- Neoplasms
- Medical Oncology
- Humans
- Disease Management
- Anticoagulants
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis